Following extensive clinical field trials DSA is now proud to introduce world’s fastest covid screening product. Just one exhalation, and our screening algorithm makes a distinction between positive or negative indication. The system is ready for a new person every 2-3 minutes. 

The DSA BreathPassTM uses a non-invasive method for indication of COVID-19 caused by the SARS-CoV-2 coronavirus. The device measures the exhaled breath for 45 seconds, characterizes the VOCs within breath samples, produces indications for different health conditions based on Deep Computing algorithms and generates results in few seconds. The DSA BreathPassTM is intended for screening asymptomatic and pre-symptomatic persons. It is a fast, easy and affordable testing method for screening large populations anywhere with a reliable connection to the internet.

For more information:            

Pekka Rissanen

Chief Executive Officer

Deep Sensing Algorithms Ltd

pekka.rissanen@dsa.fi

+358 400 648 568 

How does it work?

 

The unit contains a set of carefully selected and configured nanosensors that record Volatile Organic Compounds (VOC) and other substances connected to the biomarkers to be identified in exhaled breath gas. The biomarker VOC’s are born in human metabolism and their known relation – the VOC profile – with a given disease forms the basis for the analysis.

DSA BreathPass™ communicates with an Artificial Intelligence based cloud algorithm to calculate how well the measured breathprint of the individual’s VOC profile matches with the known COVID-19 features. The results are available immediately.

View Data Sheets

Deep Sensing Algorithms Ltd Oy

Tuurnankatu 5
FI-33270 Tampere
Finland

Business ID: 3139958-7

Visiting address:
Hämeenkatu 14 C 25
FI-33100 Tampere
Finland

See map »

 

Copyright © 2022 Deep Sensing Algorithms Ltd Oy